B-MS recalls US Eliquis Lot after low dose pills found in 5mg bottle

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmacology

Source B-MS
Source B-MS
Bristol Myers Squibb (B-MS) has recalled one lot of the oral anti-clotting drug Eliquis in the US after a customer found 2.5mg strength tablets in a bottle labelled as containing 5mg tablets.

The US drug manufacturer recalled the Eliquis (apixaban) Lot - number #HN0063 - on Friday, explaining that it was a precautionary measure prompted by a customer compliant.

B-MS said it had not received reports of adverse events adding that the “distinct visible differences​” between the two tablet strengths “decrease the likelihood of an incorrect dose​.”

A spokeswoman told us the recalled lot was made at a facility in Indiana, US adding that "After thorough investigation, no definitive root cause for the issue could be determined.​"

She also told us that "No shortages are likely​" adding that "there is adequate product supply to meet patient demand.​" 

Related topics Markets & regulatory news QA/QC

Related news

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us